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Abstract
The innate immune response constitutes the first line of defense against infections. Pattern recognition receptors recognize
pathogen structures and trigger intracellular signaling pathways leading to cytokine and chemokine expression. Reactive
oxygen species (ROS) are emerging as an important regulator of some of these pathways. ROS directly interact with
signaling components or induce other post-translational modifications such as S-glutathionylation, thereby altering target
function. Applying live microscopy, we have demonstrated that herpes simplex virus (HSV) infection induces early
production of ROS that are required for the activation of NF-kB and IRF-3 pathways and the production of type I IFNs and
ISGs. All the known receptors involved in the recognition of HSV were shown to be dependent on the cellular redox levels
for successful signaling. In addition, we provide biochemical evidence suggesting S-glutathionylation of TRAF family
proteins to be important. In particular, by performing mutational studies we show that S-glutathionylation of a conserved
cysteine residue of TRAF3 and TRAF6 is important for ROS-dependent activation of innate immune pathways. In conclusion,
these findings demonstrate that ROS are essential for effective activation of signaling pathways leading to a successful
innate immune response against HSV infection.
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Introduction
The innate immune response constitutes the first line of
defense against invading pathogens, and relies on pattern
recognition receptors (PRR)s for detection of infections through
recognition of either molecular structures specific for non-self, or
aberrant localization of molecules used by both host and microbe
[1,2]. Toll-like receptors (TLR)s are membrane-bound PRRs
localized in the plasma membrane and endosomes, which
recognize microbes at these sites. Other families of PRRs are
localized in the cytoplasm, such as Retinoic acid-inducible gene
(RIG)-I-like receptors (RLR)s which detect cytosolic RNA [1,2].
The RLRs, including RIG-I and Melanoma differentiation-
associated gene-5 (Mda-5), signal from the outer mitochondrial
membrane via anchoring of the mitochondrial RLR adaptor
molecule, MAVS (mitochondrial antiviral signaling protein) [3].
Cytosolic DNA potently stimulates innate immunity through a
series of DNA receptors (DNAR)s including the AIM2-like
receptors (ALR)s [3–7].
Herpes simplex virus (HSV) is a significant human pathogen,
and whilst HSV-1 is an important cause of viral encephalitis,
HSV-2 predominantly causes genital infections [8]. HSV-1 and 2
are closely related at the genetic level and accordingly share many
biological and pathological properties [8]. HSV is recognized by
TLR2 and TLR9 [9,10], which act synergistically to control HSV
infection in the brain in mice [11]. In humans, a dominant-
negative TLR3 allele has been reported in otherwise healthy
children with HSV-1 encephalitis [12]. In addition to TLRs, both
RLRs and DNARs have been implicated in recognition of herpes
viruses [3,5–7,13]. Most recently, we have identified c-interferon-
inducible protein 16 (IFI16) as a novel intracellular sensor of HSV
DNA and mediator of expression of type I interferon (IFN) and
inflammatory cytokines [7]. Thus, innate recognition of HSV
involves a large spectrum of PRRs, which together orchestrate the
innate immune response to infections by this virus [reviewed in ref.
14].
The innate immune system interacts closely with basic cellular
processes such as autophagy and reactive oxygen species (ROS)
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innate immune response. Oxygen is consumed during many
cellular processes in a manner leading to production of
superoxide anions (O2
-) [17–19], which are readily converted to
hydrogen peroxide (H2O2) by a reaction catalysed by superoxide
dismutases. Both superoxide anions and hydrogen peroxide can
be converted to other reactive species (e.g., hydroxyl radical,
peroxynitrite, etc.) through reactions with a range of reactive
molecules in the cell. ROS is a collective term for superoxide and
the downstream-derived ions and small molecule metabolites.
Due to the highly reactive nature of ROS that can modify any
cellular macromolecule, the cell contains several scavengers,
called antioxidants, as well as enzymes that maintain cellular
redox homeostasis. Glutathione (GSH) is the most abundant
cellular antioxidant. GSH can form molecular disulfides with the
thiol group of the cysteine residues in oxidative conditions,
thereby regulating protein function [20]. This modification has
been shown to be essential for the function of several proteins
such as c-jun, p50/NF-kBa n dI kB kinase subunit (IKK) b [21–
23]. It has long been known that ROS play an important part in
the innate immune system as a microbicidal compound produced
by NADPH oxidases (NOXs) in phagosomes of phagocytic cell
types such as macrophages and neutrophils [18]. More recently,
it has been demonstrated that ROS are also involved in
activation and regulation of a wider range of processes in the
innate immune system, including autophagy, signal transduction,
gene expression, activation of the inflammasome, and pro-
grammed necrosis [15,16,24–28]. Thus, cellular sensing of the
intracellular redox status impacts on the immune response to
infectious agents.
The recognition of viruses by the immune cells is a very
complex process in which several signal transduction pathways
regulating numerous cellular processes are involved. Moreover,
the recent observation of the involvement of ROS as a regulator
of these processes gives an additional layer of complexity that
needs to be described. In this work, we demonstrate that HSV
infection induces an early production of ROS, which regulates
the activation of innate immune responses initiated by HSV
infection, via TLRs, RLRs, and IFI16. Mechanistically, we show
that ROS induces S-glutathionylation of tumor necrosis factor
receptor-associated factor (TRAF) 3 and 6, which is essential for
optimal stimulation of the cellular response to innate HSV
recognition.
Results
HSV-induced ROS formation is essential for the activation
of the innate immune response
ROS has gained increasing importance in the role as a second
messenger in the activation of signaling pathways. In order to
examine how these radicals are involved in the recognition of
HSV, we first examined if HSV infection induced formation of
cellular ROS. RAW264.7 cells were infected with HSV-2 and
ROS formation at different time points was monitored by live
microscopy using the oxidant-sensitive fluorescent probe CM-
DCFDA. ROS production was induced 1 h post-infection
(Figure 1A), and this was abrogated by pre-treating the cells with
the antioxidant N-acetyl-L-cysteine (LNAC), which can scavenge
endogenous ROS (Figure 1A). LNAC did not affect viral entry as
determined by staining for viral capsids in the cytoplasm following
infection (data not shown). Next, the role of ROS in HSV-
stimulated cytokine expression was examined. We first investigated
the effect of exogenous ROS on expression of IFNs and IFN-
stimulated genes (ISG)s in response to HSV infection. Murine
primary macrophages responded to HSV-2 infection with
production of type I IFN (Figure 1B) and the IFN-inducible
chemokines CXCL10 (Figure 1C) and CCL5 (Figure 1D), and in
all cases exogenous hydrogen peroxide (H2O2) lead to a modest
but significant elevation of this response. On the contrary, pre-
treatment with the general antioxidants pyrrolidine dithiocarba-
mate (PDTC) and LNAC strongly inhibited the cytokine response
following infection with HSV-2 (Figure 1E, F). All small molecule
inhibitors were used in concentrations not affecting cell viability as
determined by annexin V and propidium iodide staining in
macrophages (data not shown).
To examine how modulation of ROS levels affected the ability
of HSV to activate the innate immune response in different
immune cell types, we treated pDCs and macrophages with
LNAC prior to infection with HSV-1 or -2. The subsequent CCL5
expression was evaluated by ELISA. Although these cell types
stimulate the innate immune response against HSV infection
through different combinations of PRRs, they all displayed the
same inhibitory effect of the antioxidant (Figure 2A, B). Similar
findings were obtained with murine embryonic fibroblasts (MEF)s
treated with LNAC and infected with HSV-1 or -2 (Figure 2C).
Once the role of ROS was confirmed in vitro, we evaluated their
potential function in innate antiviral defense in vivo. With this
purpose, we treated mice with LNAC prior to infection with HSV-
2. The virus-induced production of type I IFN was inhibited in
mice receiving LNAC (Figure 2D), and these mice exhibited
elevated viral load in the liver after day 1 post infection (Figure 2E).
Collectively, these data demonstrate that HSV infection induces
formation of cellular ROS, which are essential for the activation of
an antiviral innate immune response in vitro and in vivo.
ROS are essential for activation of NF-kB and IRF-3
signaling induced by HSV infection
The signaling pathways upstream of the transcription factors
NF-kB and IRF-3 are important for establishment of innate
antiviral defense against HSV [1,2]. To clarify whether activation
of these pathways was modulated by ROS, we examined how
treatment with LNAC prior to HSV infection affected phosphor-
ylation of the NF-kB inhibitor IkBa and activation of IRF-3 by
nuclear translocation. We observed that the infection led to strong
phosphorylation of IkBa after 5 h, and that this was potently
inhibited by LNAC (Figure 2F). Likewise, HSV-induced translo-
cation of IRF-3 to the nucleus was largely abrogated by pre-
treatment with LNAC (Figure 2G). Thus, the signaling pathways
Author Summary
Herpes simplex virus (HSV) type 1 and 2 are important
human pathogens, which can give rise to severe diseases
during both primary and recurrent infections. In addition
to activating ‘‘classical’’ innate and adaptive immune
responses, many infections stimulate other cellular activ-
ities such as and production of reactive oxygen species
(ROS). However, there is little knowledge on the cross-talk
between ROS and the innate antiviral response. In this
article we show that HSV infection leads to production of
ROS, and that ROS play a critical role in activation of innate
immune responses to these viruses. At the mechanistic
level, we show that ROS stimulate glutathionylation (a
protein modification) of the signaling molecules TRAF3
and 6, which promotes redox-sensitive signaling. Our data
support the idea that the innate immune system not only
detects specific HSV molecules but also senses the cellular
oxidative stress level, and integrates this into the innate
immune response to infections.
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of cellular ROS.
The MAPK kinase kinase apoptosis signal-regulating kinase
(ASK) 1 has been reported to be involved in ROS-dependent
innate immune signaling pathways upstream of MAPKs and IRF-
3 following lipopolysaccharide (LPS) treatment [16,26]. To test the
role of ASK1 in ROS-dependent innate antiviral immune
responses, peritoneal macrophages from C57BL/6 and ASK1
-/-
mice were infected with HSV-2 in vitro. As expected, the culture
supernatants from infected cells contained elevated levels of CCL5
and IFN-a/b as compared to the supernatants from untreated
cells, but no significant difference was observed between the
C57BL/6 and ASK1
-/- cells (Figures 2H, I). Mice were infected
with HSV-2 via the intraperitoneal route, and livers harvested
after 3 days for analysis of viral load by plaque assay. High levels of
virus were observed in the livers from C57BL/6 mice, and no
impairment in the antiviral defense was observed in the ASK1
-/-
mice (Figure 2J). Thus, HSV infection stimulates ROS-dependent
activation of NF-kB and IRF-3 in a manner independent of
ASK1.
ROS are essential for innate antiviral immune activation
via both TLRs and intracellular PRRs
HSV stimulates the innate immune system through multiple
PRRs and in cell-type specific manners [13]. In macrophages,
HSV-1 induced expression of type I IFN, independently of MAVS
(RLRs) (Figure 3A) and TLR2/9 (Figure 3B). We have recently
shown that HSV-1 is sensed by IFI16 [7]; consistent with this,
Figure 1. Intracellular ROS produced following HSV infection is essential for cytokine expression. (A) RAW264.7 cells were seeded in
chambered-cover slides, either pre-treated with 6.4mM LNAC or complete media for 30 min, and subsequently infected with HSV-2 for 1, 2, or 3 h.
CM-H2DCFDA (5 mM) was added immediately before imaging. ROS production was monitored in z-stack images (1 mm) and images were acquired
with a 40x objective every 30 seconds by confocal microscopy. Images represent maximum intensity projections. Amount of ROS was determined
and represented as mean fluorescence per cell with a minimum of 100 cells counted per condition. Data is presented as mean of 3 experiments for
the untreated samples and of 2 experiments for the LNAC samples +/- sem. (B–D) Peritoneal macrophages were seeded and either left uninfected or
infected with HSV-2 (3610
6 pfu/ml, MOI 3); each in the absence or presence of 10 mM hydrogen peroxide. Supernatants were harvested after 16 h for
measurement of IFN-a/b, CXCL10, and CCL5. (E, F) Peritoneal macrophages were pre-incubated with increasing concentrations of PDTC or LNAC and
subsequently infected with HSV-2 (3610
6 pfu/ml, MOI 3). Supernatants were harvested 12 h post infection and CCL5 protein was measured by ELISA.
The data is shown as mean of 3 replicates +/- st. dev. and is representative of 3 experiments. CCL5 levels significantly different from those induced by
HSV-2 alone (p,0.05) are indicated with *.
doi:10.1371/journal.ppat.1002250.g001
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PLoS Pathogens | www.plospathogens.org 3 September 2011 | Volume 7 | Issue 9 | e1002250Figure 2. Redox-sensitive signaling following HSV recognition. (A) pDCs and (B) BMMs were treated with LNAC (3.2 mM) 30 min prior to
infection with HSV-1 or 2 (MOI 3). Culture supernatants were harvested 16 h post infection, and levels of CCL5 were measured by ELISA. All data are
shown as means of 3–5 replicates +/- st.dev. (C) MEFs were treated with LNAC (3.2 mM) 30 min prior to infection with HSV-1 or 2 (MOI 3). Total RNA
was harvested after 6 h post-infection and IFN-b mRNA measured by real time PCR. Data is presented as means of triplicate measurements +/- st.dev.
RU, relative units. (D, E) Mice were treated i.p. with LNAC (1.1 mmol/kg body weight) in saline or with saline alone followed 4 h later by infection with
HSV-2 (5610
6 pfu). Eight and 24 hours post infection, serum and livers were harvested for measurement of type I IFN and viral load, respectively
(n=5). Data represents mean of 3–6 replicates +/- st.dev. (F, G) RAW264.7 macrophage-like cells were treated with LNAC (6.4 mM) for 30 min before
infection with HSV-2 (3610
6 pfu/ml, MOI 3). (F) Total cell lysates were harvested at the indicated time points post infection, and phospho-IkBa was
measured by Luminex. (G) The cells were fixed 3 h post infection, stained with anti-IRF-3 antibody and DAPI, and visualised by confocal microscopy.
Cells were scored for nuclear IRF-3 staining. Data represent mean +/- st.dev. (H, I) Peritoneal macrophages from C57BL/6 WT and ASK1
-/- mice were
cultured in vitro and infected with HSV-2 (3610
6 pfu/ml, MOI 3). Supernatants were harvested 16 h post infection, and the levels of CCL5 and IFN-a/b
were measured. (J) C57BL/6 WT and ASK1
-/- mice were infected i.p. with 5610
6 pfu of HSV-2. Livers were isolated 3 days post infection and viral load
in the organs was determined (n=8). The data represent mean of multiple measurements +/- st.dev.
doi:10.1371/journal.ppat.1002250.g002
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dependent on the IFI16 murine ortholog, p204 (Figure 3D). In
contrast, pDCs responded to the infection in a manner entirely
dependent on TLR9 (Figure 3C). To further investigate the effect
of ROS modulation on the activation of the PRRs that were
reported to be involved in HSV recognition, we treated
RAW264.7 cells with LNAC prior to stimulation with specific
ligands for: cytoplasmic DNA sensors (HSV-1 60-mer), TLR2
(Pam3Csk4), TLR3 (poly(I:C)), TLR9 (ODN1826), and RLRs
(poly(I:C):LyoVec)) (Figure 3E–G). Pre-incubation with LNAC
strongly diminishes CCL5 production in response to HSV-1
60mer (Figure 3E). Similarly, stimulation via TLRs and RLRs
induced a strong expression of CCL5, which was abrogated by
pre-treatment with LNAC (Figure 3F, G). Collectively, these data
demonstrate that all the PRRs reported to be involved in
recognition of HSV are inhibited by general depletion of cellular
ROS, indicating a positive role for ROS in the regulation of the
innate immune response to HSV.
ROS mediate glutathionylation of TRAF family proteins
ROS can influence signal transduction through many mecha-
nisms [16,29,30]. However, one of the most important mecha-
nisms involves reversible S-glutathionylation of cysteine residues
that alters protein function either by changing the protein active
site or modifying protein-protein interactions [20]. To address
whether S-glutathionylation could be involved in the positive
stimulatory roles of ROS on innate immune signaling, we treated
cells with the GSH-depleting agents buthionine sulfoximine and
diethylmaleate prior to infection with HSV-2 [31]. Diminution of
cellular GSH levels decreased the ability of HSV-2 to induce IFN-
b and CCL5 mRNA expression (Figure 4A, B). To further address
the potential role of S-glutathionylation in ROS-dependent
positive stimulation of innate immune signaling, we transduced
RAW264.7 cells with recombinant adenovirus (AdV) expressing
glutaredoxin (Adv-Grx) 1, in order to decrease S-glutathionylation,
or with an empty vector adenovirus (Adv-vector). Glutaredoxin
overexpression decreases S-glutathionylation of proteins by
catalyzing deglutathionylation freeing the protein thiol groups.
Infection of the cells with HSV-2 or stimulation with the TLR9
ligand ODN1826 led to accumulation of CCL5 and IFN-a/b in
the culture supernatants of the cells expressing AdV-vector and
this response was significantly decreased in cells expressing Adv-
Grx (Figure 4C, D). TRAF family proteins have been reported to
be sensitive to redox-dependent regulation of signal transduction
[16,32], and we therefore examined whether ROS affected the
glutathionylation of TRAF3 and TRAF6, which are critically
involved in activation of pathways upstream of IRF-3 and NF-kB,
respectively. Interestingly, H2O2 treatment, which elevated HSV-
induced cytokine expression (Figure 1B–D), led to a clear increase
in GSH moieties associated with both TRAF3 and TRAF6
(Figure 4E, F). Importantly, glutathionylation of TRAF 3 and 6
was also observed following HSV-2 infection (Figure 4G, H).
Figure 3. ROS and innate antiviral response: Cell-type and PRR dependence. (A, B) Macrophages were isolated from C57BL/6 WT, MAVS
-/- or
double knock-out TLR2/9
-/- mice and cultured in vitro. Cells were treated with (A) HSV-1 KOS or Sendai Virus, or (B) HSV-1 KOS or ODN1826.
Supernatants were harvested after 16 h and presence of type I IFNs were measured by bioassay. (C) pDCs were isolated from C57BL/6 WT or TLR9
-/-
mice. Cells were treated with HSV-1 KOS or ODN1826. Supernatants were harvested after 16 h and presence of type I IFNs were measured by
bioassay. (D) RAW264.7 macrophage-like cells were transfected with si-p204 or control siRNA and infected with HSV-1 KOS. Total RNA was harvested
after 6 h post-infection and CCL5 mRNA measured by real time PCR. Data is presented as mean of duplicate measurements +/- st.dev. RU, relative
units. (E) RAW264.7 cells were transfected with HSV1-60mer (2 mg/ml) following treatment with 6.4 mM LNAC or complete media. Culture
supernatants were harvested 12 h p.i. and production of CCL5 was measured by ELISA. (F) RAW264.7 cells were seeded and treated with vehicle or
LNAC (3.2 mM) 30 min prior to stimulation with Pam3Csk4 (200 ng/ml), ODN1826 (1 mM), and poly(IC):LyoVec (25 mg/ml). Culture supernatants were
harvested 16 h post-stimulation, and levels of CCL5 were measured by ELISA. (G) RAW264.7 cells were incubated with poly(I:C) (25 mg/ml) following
treatment with 6.4 mM LNAC or complete media. Culture supernatants were harvested 16 h p.i. and production of CCL5 was measured by ELISA.
Data represents mean of measurements from triplicate cultures +/- st.dev.
doi:10.1371/journal.ppat.1002250.g003
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revealed a cysteine residue in the b3 sheet in the TRAF C-terminal
domain, which is conserved between TRAF2, 3, and 6, in both
rodents and humans (Figure 5A). Examination of the structure of
the TRAF6 C-terminal domain complexed with a peptide from
RANK (PDB ID 1LB5) showed that this residue (Cys390) is
surface-exposed and localized in close proximity to the peptide-
binding pocket [33]. We docked GSH onto the structure of the
TRAF6 C-terminal domain in the proximity of Cys390. The
docking revealed that the structure was compatible with
glutathionylation of Cys390, as the only clash was with Arg466
(data not shown). However, this clash could be relieved by
changing the side chain conformation of Arg466, directing it
further towards the RANK binding pocket. Thus, glutathionyla-
tion of Cys390 and contact between the GSH group and the
binding partners of TRAF6 is in accordance with the current
structural knowledge.
To determine the role of this potential glutathionylation site in
TRAF6 mediated signaling, wild type TRAF6 or TRAF6 C390S
mutant were transfected into Traf6-/- fibroblasts and P-IkBa
monitored in response to treatment with HSV-2 or poly(I:C).
Traf6-/- fibroblasts displayed reduced P-IkBa compared to wild
type fibroblasts in response to both HSV-2 infection and
treatment with poly(I:C) (Figure 5B). Reconstitution of Traf6-/-
fibroblasts with wild type TRAF6 returned HSV-2 and poly(I:C)-
stimulated P-IkBa to levels consistent with wild type fibroblasts
(Figure 5B, C). However, reconstitution of Traf6-/- fibroblasts
with TRAF6 C390S was unable to completely rescue P-IkBa and
IFN-b mRNA induction in response to HSV-2 and poly(I:C)
(Figure 5B, C). Furthermore, cells transfected with the C390S
mutant were less sensitive to LNAC treatment than cells
transfected with WT TRAF6 after poly(I:C) treatment and
HSV-2 infection, as measured by IkBa phosphorylation and IFN-
b mRNA (Figure 5D, E). By contrast, the ability of IL-1b to
activate the NF-kB pathway was not compromised in TRAF6
C390S-expressing cells, despite strong sensitivity towards LNAC
treatment (Figure 5F), hence suggesting differences in the mode of
action of ROS in different signaling pathways. Finally, introduc-
tion of a Cys-to-Ser mutation at position 455 in TRAF3, which
aligned with Cys390 of TRAF6, led to reduced induction of IFN-
b by HSV-2 after transfection into traf3-/- MEFs, and
importantly abolishment of the sensitivity towards LNAC
treatment, which was found in traf3-/- cells transfected with
WT TRAF3 (Figure 5G). Collectively, these data indicate that
HSV infection leads to production of ROS, which is essential for
activation of innate antiviral immune responses, and this
proceeds via a mechanism involving S-glutathionylation of TRAF
family proteins.
Figure 4. S-glutathionylation of TRAFs in response to exogenous and virus-induced ROS. (A, B) Peritoneal macrophages were treated
overnight with buthionine sulfoximine (BSO, 200 mM). Diethylmaleate (DEM, 200 mM) was added 1 h prior to infection with HSV-2 (3610
6 pfu/ml, MOI
3). Total RNA was harvested 6 h p.i., and IFN-b and CCL5 mRNA was measured by real-time PCR. RNA levels were normalized against b-actin, and data
shown as means relative units compared to untreated controls +/- st.dev. RU, relative units. (C, D) RAW264.7 cells were infected with AdV-empty
vector or AdV-Grx for 2 days (MOI 10) before stimulation with HSV-2 (3610
6 pfu/ml, MOI 3) or ODN1826 (1 mM) as indicated. Supernatants were
harvested 16 h post-stimulation and levels of IFN-a/b and CCL5 were measured. The data represent mean of triplicate cultures +/- st.dev. (E–H)
RAW264.7 cells were treated with H2O2 (10 mM) or infected with HSV-2 (1610
7 pfu/ml, MOI 10) for 4 h. Total cell lysates were subjected to
immunoprecipitation of TRAF3 and TRAF6, and the precipitates were blotted and probed with anti-glutathione antibodies.
doi:10.1371/journal.ppat.1002250.g004
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The innate immune response constitutes the first component of
the host defense machinery against pathogens. Exposure to an
invading pathogen triggers recruitment and activation of phago-
cytic cells that initiate a respiratory burst, consisting in a robust
production of ROS, in order to eliminate the invading pathogen.
However, it is increasingly believed that moderate intracellular
concentrations of ROS can act as a second messenger involved in
the activation of innate immune signaling pathways against
pathogens. In this study, we demonstrate that ROS are produced
early during HSV infection and are essential for triggering an
effective antiviral response against HSV in vivo and in vitro,
involving type I IFNs, CXCL10 and CCL5 secretion.
There are several reports describing ROS production induced
by viral infection, such as hepatitis C virus, influenza A,
respiratory syncytial virus, and Sendai virus [34–37]. Lipopoly-
saccharide also stimulates ROS production via NOX and
xanthine oxidase [30,38]. Due to the high reactivity attributed
to ROS, these radicals can quickly interact with the surrounding
macromolecules. This has been seen during pulmonary H5N1
influenza A virus infection where ROS production generates
Figure 5. Identification of a conserved redox-sensitive surface-exposed cysteine in the TRAF C-terminal domain of TRAF2, 3, and 6.
(A) Structure-based sequence alignment of a region of the TRAF domain of human and murine TRAF2, 3, 4, and 6. Secondary structures in the region
and TRAF-motif interacting residues are indicated in the figure. (B) Traf6-/- MEFs were left untreated or treated with HSV-2 (3610
6 pfu/ml, MOI 3, 5 h)
or poly(I:C) (25 mg/ml, 2 h). Total cellular lysates we generated and phospho-IkBa was measured by Luminex. (C–F) Traf6-/- MEFs were transfected
with empty vector (pCMV), WT TRAF6, or C390S TRAF6. The cells were treated with HSV-2 (3610
6 pfu/ml, MOI 3, 5 h), poly(I:C) (25 mg/ml, 2 h), IL-1b
(10 ng/ml), and LNAC (3.2 mM, 30 min prior to further treatment) as indicated. Total RNA and total cell lysates were isolated and analyzed for IFN-b
mRNA and P-IkBa by RT-qPCR and Luminex, respectively. Data is shown as means of triplicates +/- st.dev. (G) Traf3-/- MEFs were transfected with
empty vector (pRK5), WT TRAF3, or C455S TRAF3. The cells were treated with HSV-2 (3610
6 pfu/ml, MOI 3) and LNAC (3.2 mM, 30 min prior to further
treatment) as indicated. Total RNA was isolated 5 h post-infection and analyzed for IFN-b mRNA by RT-qPCR. Data is shown as means of triplicates +/-
st.dev. RU, relative units; NR, normalized ratio.
doi:10.1371/journal.ppat.1002250.g005
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role in lung injury during infection [36]. The pro-inflammatory
response triggered by H5N1 infection can be reduced with LNAC
treatment and as a result reduce lung injury [39]. Likewise, it has
been previously reported that HSV infection-induced ROS are
responsible for the formation of lipid peroxidation byproducts and
neurotoxicity, characteristic of encephalitis [40,41]. Thus, ROS
are not only produced by macrophages and neutrophils to play a
part in the killing of invading pathogens, but are a key component
for the activation of PRR signaling.
In the case of HSV, several PRRs are involved in the
recognition of the virus [14], including membrane-bound TLRs,
and cytoplasmic RLRs and DNARs [3,6,7,9,12,13,42]. Here, we
have examined the role of ROS in induction of innate immune
responses by HSV as well as all the reported receptors recognising
HSV. The data demonstrate that ROS are necessary for optimal
signaling and gene expression during HSV infection or stimulation
of PRRs. Most notably, the recently identified DNA receptor
IFI16 senses HSV DNA in the cytoplasm and initiates a signaling
cascade that is also redox-sensitive [7]. However, the sources of
ROS might be different for the various receptors since they are
located in different cellular compartments. It has previously been
reported from separate groups that increased mitochondria-
derived ROS production inhibits TLR4-mediated NF-kB activa-
tion [43,44], whereas cytoplasmic NOX-derived ROS positively
affects this activity [30]. Woo et al. have recently shed some light to
this problem. They have shown that cells stimulated via immune
receptors, such as T and B cell receptors, inactivate membrane-
bound peroxiredoxin I (PrxI) and not cytoplasmic PrxI [45]. This
allows transient localized accumulation of H2O2 around the
membranes where signaling molecules such as protein tyrosine
phosphatases are being recruited to the activated receptor [45].
Consequently, this intracellular oxidant gradient allows a regulat-
ed management of the signaling to the otherwise uncontrolled
radical interactions, due to the nature of ROS.
The recognition of viruses is coordinated at the subcellular level
by triggering signaling pathways leading to activation of
transcription factors, and consequent expression of antiviral
cytokines and chemokines. All these processes are regulated at
the post-transcriptional level, with phosphorylation being the best
described. However, other post-translational modifications have
gained increasing importance, such as oxidation, ubiquitination,
SUMOylation or glutathionylation. In this work we show that
HSV oxidative-dependent activation of NF-kB and IRF-3
pathways plays a key role downstream of the PRRs recognizing
HSV. NF-kB was the first transcription factor recognized to be
redox-regulated [46]. ROS not only activates NF-kB through
promotion of the degradation of IkBa, but also induces several
post-translational modifications of the NF-kB subunit p65 that are
necessary for the transcription of NF-kB-dependent pro-inflam-
matory genes [47]. TNF-a-induced IL-8 gene expression in
monocytes is mainly controlled at the transcriptional level through
NF-kB although redox-sensitive phosphorylation at Serine 276 of
p65 is required [48]. For the IRF-3 pathway, different outcomes
have been described in redox-dependent activation of IRF-3. It
has been reported that NOX-derived ROS stimulate activation of
the non-canonical IKK-like kinase, IKKe, and so IRF-3
activation, during infection with respiratory syncytial virus [34].
Recently, it has been shown that NOX2-derived ROS are critical
for efficient RIG-I-mediated activation of IRF-3 and induction of
IFN expression [37], whereas activation of this pathway through
TLR4 is dependent of NOX4-derived ROS and ASK1 [26].
Prinarakis et al., on the other hand reported that IRF-3 is
constitutively S-glutathionylated in HEK293 cells and is deglu-
tathionylated by Grx upon Sendai virus infection, which is
essential for the ability of IRF-3 to promote transcription [49]. In
the primary murine peritoneal macrophages used in this study,
constitutive glutathionylation of endogenous IRF-3 was not
detected (data not shown), but our data do not exclude that
ROS enhance signaling at the level of IKKe and MAVS.
Collectively, the literature on ROS and activation of PRRs
suggest that ROS interacts with signaling at multiple steps, which
may implicate that the subcellular sources of ROS as well as the
microenvironment in which a PPR operates (e.g. endosomes and
mitochondrial surfaces) impacts on the role and mechanism of
action of ROS in innate immunity. This adds a layer of complexity
to the already intricate signaling of the innate immune response.
S-glutathionylation has also been suggested to be an important
player in redox signaling [20,31]. We found that depletion of
cellular GSH levels or reversing of S-glutathionylation by
overexpression of Grx strongly inhibited HSV-induced expression
of IFNs and ISGs. Moreover, HSV-2 infection led to detectable
glutathionylation of both TRAF3 and TRAF6, which was also
seen in response to the potent ROS stimuli H2O2. Finally, a
conserved surface-exposed cysteine residue is presented in the
TRAF domain of TRAF2, 3, and 6, which is involved in redox-
sensitive signaling pathways from PRRs and cytokine receptors
[2], but not in TRAF4, which is generally believed not to be
involved in these pathways [50]. We found that mutation of this
cysteine in TRAF3 and 6 decreased the signaling and cytokine
response to HSV-2 infection as well as the redox-sensitive nature
of the response. Interestingly, a recent study demonstrated that
human glutathione S-transferase P1-1 interacts with the TRAF
domain of TRAF2 and specifically down-regulates signaling to
MAPKs [32], which together with our present findings suggests
that S-glutathionylation of TRAFs or associated protein represents
a mechanism by which ROS re-direct and amplify signaling in the
innate immune system. In contrast to this model, a recent report
based on Grx-1 knock-down in 293HEK and Hela cells suggested
that TRAF6 gets deglutathionylated in the RING finger motif
upon IL-1/TLR stimulation, which was proposed to be essential
for subsequent activation [51]. Therefore, with the available data,
it is clear that we are still at an early stage in our understanding of
the role of S-glutathionylation in immunological signal transduc-
tion.
In conclusion, we provide evidence that HSV infection quickly
induces intracellular ROS which are necessary for proper
activation of innate antiviral immune responses. The stimulatory
functions of ROS appear to be mediated through S-glutathionyla-
tion, and we suggest TRAF family proteins to be important targets
in positive ROS signaling. Recently, novel important roles for
ROS in the innate immune system have been described, including
inflammasome activation and programmed necrosis [28,52].
Thus, it is becoming increasingly evident that ROS are key
players in the host response to infection and inflammation, and
that further understanding of the molecular details underlying the
production and action of ROS may provide important knowledge
on antiviral response mechanisms and pathogenesis of many
human diseases.
Materials and Methods
Ethics statement
This study was carried out in accordance with the recommen-
dations in the Guide for Care and Use of Laboratory animals,
Institute of Laboratory Animal Resources, National Academy
press (1996). All animal experiments were done in accordance with
a protocol (permit number 2009/561-1613), which was approved
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Justice).
Mice
C57BL/6, TLR9
-/-, TLR2/9
-/- and ASK1
-/- mice [11,53,54]
were bred at M&B Taconic (Laven, Denmark) and kept in the
animal facility at The Faculty of Health Sciences, AU between the
time of delivery (at 4 to 6 weeks of age) and the time of the
experiments, and used for experiments between the age of 7 and 9
weeks old.
Cells
Peritoneal cells were harvested by lavage of the peritoneal cavity
with PBS containing 5% foetal calf serum (FCS) and 20 IU/ml
heparin. Cells were washed, counted, and re-suspended in RPMI
1640-5% FCS for sub-culturing. For in vitro experiments, the cells
were used at a concentration of 3.0610
6 cells per well in 96-well
plates in 100 ml of RPMI 1640 with 5% FCS. BMMs were
obtained as follows: femurs and tibia were surgically removed from
C57BL/6 and MAVS
-/- mice, freed of muscles and tendons, and
briefly suspended in 70% ethanol. Ends were cut, the marrow was
flushed with 10% RPMI 1640, and cell suspension was filtered
over a 70-mm cell strainer (BD Falcon) and centrifuged for 5 min
at 1330 rpm. After 2 washes, cells were resuspended at 2610
5/ml
in RPMI 1640 with 10% FCS and GM-CSF (10 ng/ml) and
seeded in bacteriological petri dishes and incubated at 37uC with
5% CO2 and media changed after 3 and 5 days. On day 7,
adherent cells were harvested from the dishes with medium
containing 10 ng/ml GM-CSF. The cells were centrifuged,
washed, and resuspended in RPMI 1640, 10% FCS, and GM-
CSF (20 ng/ml), and examined by flow cytometry for expression
of showing CD11b and CD11c (data not shown). For in vitro
experiments, the cells were used at a concentration of 1.0610
6
cells per well in 96-well plates in 100 ml medium. To isolate
primary pDCs cells from spleens from C57BL/6 and TLR9
-/-
mice, organs were surgically removed and transferred to RPMI
1640 with 5% FCS. The spleens were then transferred to a 1 mg/
ml suspension of collagenase D (Roche). The enzyme was injected
into the organ, which was subsequently cut into small pieces,
followed by incubation in collagenase D suspension for 30 min at
37uC. The suspension was filtered over a 70-mm pore size cell
strainer, spun down, and suspended in RPMI 1640–5% FCS, and
the cells were counted. After centrifugation, the cells were
resuspended in PBS with 2 mM EDTA-0.5% BSA (MACS
running buffer) in accordance with the manufacturer’s instruction
(Miltenyi Biotec). Anti-mPDCA-1 microbeads were added, and
after incubation for 15 min at 4uC the suspension was spun down
and suspended in running buffer. pDCs were then isolated in an
autoMACS separator by positive selection. For in vitro experi-
ments, the cells were used at a concentration of 1.0610
6 cells per
well in 96-well plates in 100 ml RPMI 1640 with 5% FCS.
RAW264.7 cells and MEFs (C57BL/6, traf3-/- (G. Cheng, LA,
CA, USA) and traf6-/- (T. Mak, Toronto, Canada) were grown in
DMEM supplemented with 5-10% FCS.
Reagents
The oxidant-sensitive dye 5-(and-6)-chloromethyl-29,79-dichlor-
odihydrofluorescein diacetate (CM-H2DCFDA) was purchased
from Invitrogen. Recombinant cytokines used for ELISAs were
purchased from R&D Systems. The PRR agonists Poly(IC):Lyo-
Vec, Poly(I:C), Pam3Csk4, and ODN1826 were obtained from
InvivoGen, IL-1b was from R&D Systems, and the HSV-1
dsDNA 60mer, described earlier [7], was from DNA Technology.
Activation and inhibition of ROS production and function was
achieved using H2O2 (Sigma-Aldrich), LNAC (Sigma Aldrich),
PDTC (Sigma-Aldrich), and for GSH depletion was used
buthionine sulfoximine (Fluka), diethylmaleate (Sigma-Aldrich).
All small molecule inhibitors were used in concentrations that did
not affect cell viability as determined by annexin V and propidium
iodide staining. The pCMV hTRAF6 and pRK5 hTRAF3
expression plasmids were kindly provided by Andrew G. Bowie
(Trinity College, Dublin). The TRAF6 C390S mutant was
generated using the quick change kit (Stratagene) as described
by the manufacture. The primers used were as follows. Forward:
59-CCCGGGTACAAACTGTCCATGCGCTTGCACCTTCA-
GTTACCG-39, Reverse: 59-CGGTAACTGAAGGTGCAAGC-
GCATGGACAGTTTGTACCCGGG-39. The TRAF3 C455S
mutant was generated using a similar approach and the following
primers; Forward: 59-GGCTATAAGATGTCTGCCAGGGTC-
TACC-39, Reverse: 59-GGTAGACCCTGGCAGACATCTTA-
TAGCC-39. Oligonucleotides for HSV-1 60mer were synthesised
by MWG Biotech; sequence is as follows: 59-TAAGACAC-
GATGCGATAAAATCTGTTTGTAAAATTTATTAAGGGTA-
CAAATTGCCCTAGC-39. Forward and reverse strands were
annealed by heating for 5 min to 95uC and cooling to room
temperature.
Viruses and infections in vivo
The viruses used were HSV-1 (KOS strain), HSV-2 (MS strain),
Sendai virus (Cantrell strain), AdV empty vector, and AdV-Grx
[55]. Viruses were propagated and quantified as previously
described [13,55]. For infections in vivo, mice were injected
intraperitoneally with 5610
6 pfu of HSV-2 as described previously
[13]. At later time-points, serum, peritoneal cells, and livers were
harvested for further analyses as described below. For modulation
of ROS levels in vivo, mice were treated i.p. with LNAC
(1.1 mmol/kg body weight) in saline 4 h prior to virus infection.
Virus plaque assay
Samples of snap-frozen livers were weighed, thawed, and
homogenized three times for 5 s in MEM supplemented with 5%
FCS. After homogenization the organ suspensions were pelleted
by centrifugation at 1,620 x g for 30 min, and the supernatants
used for analysis. Plaque assays were performed on Vero cells as
described previously [11].
RNA-mediated interference
The siRNAs were chemically synthesised by Qiagen (p204-
specific siRNA, 59-CGGAGAGGAAUAAAUUCAUTT-39; con-
trol siRNA, 59-UUCUCCGAACGUGUCA CGUTT-39).
RAW264.7 cells were seeded in 12-well plates at a density of
1610
5 cells per well and were transfected with siRNA at a
concentration of 12.5 pmol/ml with Lipofectamine 2000 (1 ml/
ml). The cells were treated twice with siRNA on consecutive days
and were grown for a further 48 h before stimulation. The degree
of p204 knock-down was between 50 and 80%.
Confocal microscopy
RAW 264.7 macrophages were plated at 1610
5 cells per well
onto 10mm round coverslips. Cells were treated with inhibitors
and infected with HSV-1 for 3 hr at 37uC, fixed with 4%
formaldehyde (10 min, room temperature), permeabilised with
methanol (90 sec at 420uC) and blocked with 5% normal goat
serum (15 min, room temperature). Cells were incubated with
polyclonal rabbit anti-IRF-3 (Santa Cruz Biotechnology, CA,
USA) at room temperature for 1 hr, and counterstained with
Alexa Fluor 568 conjugated anti-rabbit antibodies (Molecular
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were stained with DAPI and coverslips mounted in Pro-Long Gold
(Molecular Probes). Images were collected using Zeiss LSM710
confocal microscope 63 x oil objective. For quantification of cells
positive for nuclear IRF-3, regions of interest were identified based
on DAPI staining, and levels of nuclear IRF-3 was determined. An
arbitrary threshold was set, and percentage of positive cells in each
group was calculated. Between 95 and 150 cells were counted for
each condition and scored for IRF-3 localization.
Live-microscopy
RAW 264.7 macrophages were seeded at 5610
4 cells per well
on a 8-wells chambered coverglass (NUNC). Cells were either pre-
treated with 6,4 mM LNAC for 30 min or with vehicle and
subsequently infected with HSV-2 for 1, 2, or 3 hours. Media was
then changed to a Phenol red-free DMEM and transferred to
37uC warmed heated-chamber of the confocal microscope. Cells
were then incubated with 5 mM CM-H2DCFDA and imaged
immediately after as described by manufacturer using Zeiss
LSM710 confocal microscope 40x or 20x objectives. Z-stack
images were taken (4–5 slices of 1 mm size) at every 30 seconds for
up to 1,5 min. For quantification of ROS production, background
fluorescence was eliminated and total fluorescence was measured
in each frame using Image J software. The number cells per frame
was calculated and a minimum of 100 cells were counted per
condition. Amount of ROS was represented as fluorescence per
cell.
ELISA and Luminex
Cytokine measurements were carried out using ELISAs based
on matched antibody pairs from R&D Systems as described [13].
Levels of phosphorylated IkBa was determined using Luminex
technology and kits from Bio-Rad, and following the instructions
from the manufacturer.
Type I IFN bioassay
The bioactivity of type I IFN in culture supernatants and serum
was determined using a L929-cell based bioassay as described
previously [11]. High levels of IFN-c or IFN-l did not interfere
with the assay.
Quantitative RT-PCR
Total RNA from human and murine macrophages was purified
using the High Pure RNA Isolation kit from Roche. For cDNA
generation, RNA was subjected to reverse transcription with
oligo(dT) as primer and Expand reverse transcriptase (Roche). For
data from Figure 3D, RNA was subjected to one-step qPCR
(Stratagene). For measurement of cytokines, the cDNA was PCR-
amplified using the following primers: IFN-b, forward: 59-
CACTGGGTGGAATGAGACTAT-39,reverse: 59-GACATCT-
CCCACGTCAATC-39, CCL5, forward: 59-ACTCCCTGCT-
GCTTTGCCTAC-39, reverse: 59-GCGGTTCCTTCGAGTG-
ACA-39, b-actin, forward: 59-TAGCACCATGAAGATCAAG-
AT-39,reverse: 59-CCGATCCACACAGAGTACTT-39. Products
were measured using SYBR Green I (Qiagen) and normalized
against b-actin. For processing of data, we selected the cycle
threshold value of samples and normalized to b-actin following
standard procedures. Data were presented as relative units
compared to the average of untreated controls
Immunoprecipitation and Western blotting
Cells were washed twice in phosphate-buffered saline, and lysed
in 850 ml of lysis buffer (50 mM HEPES, pH 7.5, 150 mM NaCl,
2 mM EDTA, 10% (v/v) glycerol, 1% (v/v) Nonidet P-40,
0.5 mM DTT, Complete protease inhibitor (Roche), 0.5 mM
Na3VO4, 20 mM N-ethylmaleimide, and 50 mM a-Iodoacetoa-
mide). For immunoprecipitation, rabbit polyclonal anti-TRAF3
and rabbit polyclonal anti-TRAF6 (Santa Cruz Biotechnology,
CA, USA) were precoupled to protein A/G-Agarose beads (Santa
Cruz Biotechnology, CA, USA) overnight at 4uC. The beads were
washed twice in lysis buffer and incubated with 1.5 mg of cell
lysate per sample overnight at 4uC. The immune complexes were
washed 3 times in lysis buffer, boiled, and analyzed by standard
SDS-PAGE and Western blotting techniques using rabbit
polyclonal anti-TRAF3/6 (as above), mouse monoclonal anti-
glutathione (ViroGen, Watertown, VA, USA), and rabbit
polyclonal anti-glutaredoxin-1 antibodies (Santa Cruz Biotechnol-
ogy, CA, USA) for blotting.
Molecular modeling
One molecule of glutathione was docked onto C390 in the
published structure of TRAF6 (1LB5 and 1LB6) using the
program Coot. This was possible with only minor changes of side
chain conformation. The docking checked for steric clashes using
the built-in routines in Coot. Coordinates for glutathione was
taken from the Hicup server.
Statistical analysis
The data are presented as means 6 SD. The statistical
significance was estimated with the Student t-test or Wilcoxon
rank sum test (p values of ,0.05 were considered to be statistically
significant).
Reproducibility of data
The results shown in this work are derived from data that are
representative for the results obtained. For each series of
experiments, two to six independent repetitions were performed.
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